Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Loans - Loss Allowance (2023)

Silo Pharma (SILO) has disclosed Loans - Loss Allowance for 1 consecutive years, with $69600.0 as the latest value for Q4 2023.

  • Quarterly Loans - Loss Allowance changed N/A to $69600.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $69600.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $69600.0 for FY2023, N/A changed from the prior year.
  • Loans - Loss Allowance hit $69600.0 in Q4 2023 for Silo Pharma.
  • In the past five years, Loans - Loss Allowance ranged from a high of $69600.0 in Q4 2023 to a low of $69600.0 in Q4 2023.